Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 88,609 | 37,099 | 35,870 | 39,487 | 64,809 |
| Marketable Securities | 3,503 | 9,520 | 10,060 | 16,125 | N/A |
| TOTAL | $93,323 | $47,399 | $47,092 | $56,567 | $65,652 |
| Non-Current Assets | |||||
| PPE Net | 1,579 | 1,750 | 1,940 | 1,992 | 2,160 |
| Other Non-Current Assets | 146 | 146 | 146 | 146 | 146 |
| TOTAL | $1,725 | $1,896 | $2,086 | $2,138 | $2,306 |
| Total Assets | $95,048 | $49,295 | $49,178 | $58,705 | $67,958 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,187 | 8,025 | 7,864 | 7,705 | 7,550 |
| Accounts payable and accrued liabilities | 934 | 1,200 | 1,998 | 1,975 | 996 |
| Accrued Expenses | 3,957 | 3,343 | 2,355 | 2,038 | 2,439 |
| Other current liabilities | 4 | 5 | 5 | 63 | 55 |
| TOTAL | $15,187 | $14,678 | $14,327 | $13,886 | $13,441 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,501 | 4,610 | 6,676 | 8,700 | 10,688 |
| Deferred Revenues | 2,105 | 2,105 | 2,105 | 2,105 | 2,401 |
| Other Non-Current Liabilities | 1,377 | 1,279 | 1,165 | 984 | 857 |
| TOTAL | $6,707 | $9,244 | $11,722 | $14,092 | $16,479 |
| Total Liabilities | $21,894 | $23,922 | $26,049 | $27,978 | $29,920 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,387 | 34,148 | 28,895 | 28,864 | 28,862 |
| Common Shares | 41 | 34 | 29 | 29 | 29 |
| Retained earnings | -175,846 | -167,906 | -159,169 | -150,761 | -142,384 |
| Other shareholders' equity | 2 | 3 | 11 | 14 | 0 |
| TOTAL | $73,154 | $25,373 | $23,129 | $30,727 | $38,038 |
| Total Liabilities And Equity | $95,048 | $49,295 | $49,178 | $58,705 | $67,958 |